Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Central Nervous System Involvement Does Not Worsen Survival in Hematologic or Molecular Relapse of Adult Acute Lymphoblastic Leukemia Patients - Retrospective Analysis By the Czech Leukemia Study Group for Life (CELL)

Stepan Hrabovsky, Cyril Salek, Frantisek Folber, Jan M Horacek, Tomas Szotkowski, Zdenek Koristek, Jozef Lukas, Tomas Arpas, Denisa Bakesova, Martin Cernan, Veronika Bergerova, Jiri Sramek, Jan Novak, Michael Doubek

Blood (2024) 144 (Supplement 1): 2806.

https://doi.org/10.1182/blood-2024-201770

Published: 2024

Journal Articles

Interferon-Related DNA Damage Resistance Signature Genes Predict Chemoresistance in Acute Myeloid Leukemia

Ela Cerovska, David Kundrat, Zdenek Krejcik, Cyril Salek, Jan Musil, Michaela Dostalova Merkerova, Monika Belickova, Hana Remesova

Blood (2024) 144 (Supplement 1): 4294.

https://doi.org/10.1182/blood-2024-203188

Published: 2024

Journal Articles

Somatic Mutations in Cancer-Related Genes Were Observed More Frequently in AYA CML Patients Compared to Elderly at Diagnosis, Whereas the Frequency Was Markedly Higher in Elderly Patients during TKI Treatment

Jitka Krizkova, Vaclava Polivkova, Nikola Curik, Adam Laznicka, Adela Benesova, Hana Klamova, Marketa Stastna Markova, Dana Srbova, Jan Zuna, Marketa Zaliova, Jan Trka, Pavel Semerak, Tomas Kalina, Cyril Salek, Katerina Machova Polakova

Blood (2023) 142 (Supplement 1): 4544.

https://doi.org/10.1182/blood-2023-189017

Published: 2023

Journal Articles

Changes of Transcriptomic Landscape in Blasts of Responding and Refractory Acute Myeloid Leukemia Patients after Chemotherapy

Ela Cerovska, Cyril Salek, David Kundrat, Zdenek Krejcik, Monika Belickova, Jaroslav Cermak, Hana Remesova

Blood (2022) 140 (Supplement 1): 9130–9131.

https://doi.org/10.1182/blood-2022-162176

Published: 2022

Journal Articles

Single Cycle of Blinatumomab Followed By High-Dose Chemotherapy in the Induction Therapy for Ph-Negative Acute Lymphoblastic Leukemia in Adults. Primary Endpoint Analysis of the Blina-Cell Trial

Cyril Salek, Frantisek Folber, Stepan Hrabovsky, Zdenek Koristek, Jan M Horacek, Eva Fronkova, Petr Soukup, Katerina Benkova, Petr Cetkovsky, Jan Trka, Michael Doubek

Blood (2022) 140 (Supplement 1): 3258–3259.

https://doi.org/10.1182/blood-2022-157361

Published: 2022

Journal Articles

Fractionated Inotuzumab Ozogamicin Combined with Low-Intensity Chemotherapy Provides Very Good Outcome in Older Patients with Newly Diagnosed CD22+ Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia: First Results from the EWALL-INO Study

Patrice Chevallier, Thibault Leguay, Michael Doubek, Francoise Huguet, Cyril Salek, Aurélie Cabannes, Ulla Wartiovaara-Kautto, Colombe Saillard, Emmanuel Raffoux, Thomas Cluzeau, Stéphane Leprêtre, Marie Balsat, Anna Berceanu, Nicolas Boissel, Emmanuelle Clappier, Laure Morisset, Claude Gardin, Hervé Dombret, Philippe Rousselot

Blood (2021) 138 (Supplement 1): 511.

https://doi.org/10.1182/blood-2021-148625

Published: 2021

Journal Articles

Real-World Effectiveness and Safety of Blinatumomab in Adults with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukaemia in Europe: 3-Year Results in Philadelphia Chromosome-Negative Patients and a Subset of Patients with Late First Relapse

Xavier Thomas, MD PhD, Anita W Rijneveld, MD PhD, Nicola Fracchiolla, MD, Cyril Šálek, MD, Alexandros Spyridonidis, MD PhD, Sabina Chiaretti, MD PhD, Naufil Alam, PhD, Isabella Pezzani Grueter, PharmD, Abeera Mohammad, MSc, William Kormany, MD, Georg Kreuzbauer, MD, Alessandro Rambaldi, MD

Blood (2020) 136 (Supplement 1): 38–39.

https://doi.org/10.1182/blood-2020-134470

Published: 2020

Journal Articles

Methscore As a New Prognostic Tool for Complex DNA Methylation Changes Assessment in Patients with Acute Myeloid Leukemia

Sarka Sestakova, Cyril Šálek, MD, Dávid Kundrát, Ivana Ježíšková, Jiří Mayer, Zdeněk Ráčil, Petr Cetkovský, Hana Remešová

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-137380

Published: 2020

Journal Articles

The Validation of the BCR/ABL1 -like Predictor across Laboratories Shows Reproducibility of Results

Sabina Chiaretti, MD PhD, Taherinasab Akram, Canichella Martina, Monica Messina, Alfonso Piciocchi, Cyril Šálek, MD PhD, Katerina Machova, Katerina Blagoevova, Jordi Ribera, PhD, Josep-Maria Ribera, MD PhD, Manja Meggendorfer, PhD, Claudia Haferlach, MD, Anna Guarini, PhD, Robin Foà, MD

Blood (2019) 134 (Supplement_1): 5211.

https://doi.org/10.1182/blood-2019-122116

Published: 2019

Journal Articles

Ponatinib Treatment in CML and Ph+ ALL Patients: Real-Life Data from the Czech Registries

Eva Koriťáková, RNDr., PhD, Michael Doubek, MD PhD, Edgar Faber, MD PhD, Daniela Žáčková, MD PhD, Jan M. Horáček, MD PhD, Petra Bělohlávková, MD PhD, Eduard Cmunt, MD PhD, František Folber, MD PhD, Pavel Jindra, MD PhD, Hana Klamová, MD PhD, Zdeněk Kořístek, MD PhD, Lukáš Stejskal, MD, Tomáš Szotkowski, MD PhD, Cyril Šálek, MD PhD, Renata Kellnerová, MD PhD, Marika Chrápavá, Mgr.

Blood (2019) 134 (Supplement_1): 5905.

https://doi.org/10.1182/blood-2019-126395

Published: 2019

Journal Articles

Importance of Transcription Factor Nrf2 for Cereblon Expression and Clinical Response to Combination of Lenalidomide and Erythropoietin in Lower-Risk Myelodysplastic Syndromes

Radka Bokorová, MSc, Jaroslav Polak, MSc, Anna Jonasova, MD, Radana Neuwirtova, MD PhD, Marie Lauermannova, MD, Jaroslav Cermak, MD PhD, Marketa Stastna, MD PhD, Cyril Salek, Dana Mikulenkova, MD, Zuzana Zemanova, PhD, Jana Brezinova, Kyra Michalova, PhD, Denisa Myslivcova, PhD, Ota Fuchs, PhD

Blood (2018) 132 (Supplement 1): 5507.

https://doi.org/10.1182/blood-2018-99-115803

Published: 2018

Journal Articles

Gene Aberrations in Adult Patients with Ph-Negative ALL in the Czech Republic

Zuzana Vrzalova, PhD, Hana Jelinkova, Stepan Hrabovsky, Frantisek Folber, MD PhD, Cyril Salek, Jan Horacek, Marketa Zaliova, Jiri Stika, Martina Slavikova, Sarka Pospisilova, Michael Doubek, MD PhD

Blood (2018) 132 (Supplement 1): 4090.

https://doi.org/10.1182/blood-2018-99-118308

Published: 2018

Journal Articles

Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients

Jitka Fucikova, Iva Truxova, Michal Hensler, Etienne Becht, Lenka Kasikova, Irena Moserova, Sarka Vosahlikova, Jana Klouckova, Sarah E. Church, Isabelle Cremer, Oliver Kepp, Guido Kroemer, Lorenzo Galluzzi, Cyril Salek, Radek Spisek

Blood (2016) 128 (26): 3113–3124.

https://doi.org/10.1182/blood-2016-08-731737

Published: 2016

Includes: Supplemental data

Journal Articles

PD-L1 Is Frequently Expressed in Acute Myeloid Leukemia Patients with Leukocytosis

Barbora Brodská, PhD, Ota Fuchs, PhD, Petra Otevřelová, Cyril Salek, MD PhD, Kateřina Kuželová, PhD

Blood (2016) 128 (22): 5229.

https://doi.org/10.1182/blood.V128.22.5229.5229

Published: 2016

Journal Articles

Rapid Identification of BCR/ABL1 -like Acute Lymphoblastic Leukemia (ALL) Cases By Quantitative Real Time-PCR (Q-RT-PCR). Generation and Validation of a Predictive Statistical Model

Sabina Chiaretti, Sara Grammatico, Alfonso Piciocchi, Monica Messina, Anna Lucia Fedullo, Valentina Gianfelici, Grazia Fazio, PhD, Nadia Peragine, Maria Paola Martelli, Paola Fazi, Marco Vignetti, Antonella Vitale, Cyril Salek, Gianni Cazzaniga, PhD, Anna Guarini, Robin Foà

Blood (2015) 126 (23): 1410.

https://doi.org/10.1182/blood.V126.23.1410.1410

Published: 2015

Journal Articles

CBFβ/MYH11 Hypomethylation Signature In Patients With Acute Myeloid Leukaemia

Hana Hajkova, Markus H.-Y. Fritz, Jiri Schwarz, Jana Markova, Martin Vostry, Zdenek Krejcik, Cyril Salek, Ota Fuchs, PhD, Petr Cetkovsky, Jaroslav Cermak, Cedrik Haskovec, Vladimir Benes

Blood (2013) 122 (21): 3774.

https://doi.org/10.1182/blood.V122.21.3774.3774

Published: 2013

Journal Articles

Ultradeep-Amplicon Pyrosequencing for Mutation Detection in the Kinase Domain of BCR-ABL Revealed Artificial Low-Level Variants That Need to Be Avoided for Relevant Mutational Data Interpretation

Adela Brouckova, Simona Soverini, Caterina De Benedittis, Hana Klamova, Cyril Salek, Marek Trneny, MD, Michele Baccarani, MD, Giovanni Martinelli, Katerina Machova Polakova

Blood (2012) 120 (21): 1396.

https://doi.org/10.1182/blood.V120.21.1396.1396

Published: 2012

NARROW

Central Nervous System Involvement Does Not Worsen Survival in Hematologic or Molecular Relapse of Adult Acute Lymphoblastic Leukemia Patients - Retrospective Analysis By the Czech Leukemia Study Group for Life (CELL)

Interferon-Related DNA Damage Resistance Signature Genes Predict Chemoresistance in Acute Myeloid Leukemia

Somatic Mutations in Cancer-Related Genes Were Observed More Frequently in AYA CML Patients Compared to Elderly at Diagnosis, Whereas the Frequency Was Markedly Higher in Elderly Patients during TKI Treatment

Changes of Transcriptomic Landscape in Blasts of Responding and Refractory Acute Myeloid Leukemia Patients after Chemotherapy

Single Cycle of Blinatumomab Followed By High-Dose Chemotherapy in the Induction Therapy for Ph-Negative Acute Lymphoblastic Leukemia in Adults. Primary Endpoint Analysis of the Blina-Cell Trial

Fractionated Inotuzumab Ozogamicin Combined with Low-Intensity Chemotherapy Provides Very Good Outcome in Older Patients with Newly Diagnosed CD22+ Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia: First Results from the EWALL-INO Study

Real-World Effectiveness and Safety of Blinatumomab in Adults with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukaemia in Europe: 3-Year Results in Philadelphia Chromosome-Negative Patients and a Subset of Patients with Late First Relapse

Methscore As a New Prognostic Tool for Complex DNA Methylation Changes Assessment in Patients with Acute Myeloid Leukemia

The Validation of the BCR/ABL1 -like Predictor across Laboratories Shows Reproducibility of Results

Ponatinib Treatment in CML and Ph+ ALL Patients: Real-Life Data from the Czech Registries

Importance of Transcription Factor Nrf2 for Cereblon Expression and Clinical Response to Combination of Lenalidomide and Erythropoietin in Lower-Risk Myelodysplastic Syndromes

Gene Aberrations in Adult Patients with Ph-Negative ALL in the Czech Republic

Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients

PD-L1 Is Frequently Expressed in Acute Myeloid Leukemia Patients with Leukocytosis

Rapid Identification of BCR/ABL1 -like Acute Lymphoblastic Leukemia (ALL) Cases By Quantitative Real Time-PCR (Q-RT-PCR). Generation and Validation of a Predictive Statistical Model

CBFβ/MYH11 Hypomethylation Signature In Patients With Acute Myeloid Leukaemia

Ultradeep-Amplicon Pyrosequencing for Mutation Detection in the Kinase Domain of BCR-ABL Revealed Artificial Low-Level Variants That Need to Be Avoided for Relevant Mutational Data Interpretation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only